Advances in the Diagnosis and Management of Lung Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 88
Special Issue Editors
Interests: research updates in pleural effusions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue "Advances in the Diagnosis and Management of Lung Cancer" focuses intently on the latest scientific advancements in diagnosing lung cancer. This comprehensive collection explores the sophisticated imaging modalities, biomarker screenings, and other diagnostic techniques that are revolutionizing our ability to detect lung cancer at its earliest stages. The articles in this Special Issue delve into the latest advancements in radiological imaging, including high-resolution computed tomography and positron emission tomography, which are enabling more precise and accurate lung cancer detection. Additionally, this Special Issue highlights the role of genetic testing and biomarker analysis in lung cancer diagnosis, providing insights into the potential of personalized medicine in this field. This collection offers a valuable overview of the latest trends and developments in lung cancer diagnosis, enabling healthcare professionals to stay updated with the latest practices and improve early detection rates, ultimately leading to better patient outcomes.
Dr. George Z. Cheng
Dr. Ara Chrissian
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genomic-based diagnostic markers
- imaging techniques for lung cancer detection
- liquid biopsy in lung cancer diagnostics
- artificial intelligence in lung cancer screening
- early detection biomarkers
- molecular profiling for lung cancer diagnosis
- endoscopic advances in lung cancer diagnosis
- precision diagnostics in lung cancer
